The Sema4 Story

Unlocking Answers to Your Health

Sema4™ is a health information company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.

A Mount Sinai Health System venture based in Stamford, Connecticut, Sema4 is enabling physicians and consumers to more seamlessly engage the digital universe of data, from genome test results and clinical records to wearable sensor metrics and more.

The company currently offers advanced genome-based diagnostics and is building predictive models of complex disease.

We believe that patients should be treated as partners, and that data should be shared for the benefit of all.

News

  •  
    SEMA4 PRESS RELEASE | 10.17.17

    Sema4 Announces Collaboration with California Cryobank to Improve and Expand Genetic Screening for Sperm Donors

    “Sema4, a Mount Sinai venture providing advanced genomic testing, and California Cryobank (Cryobank), the worldwide leader in frozen donor sperm and egg banking, today announced a collaboration to bring comprehensive genetic screening to new Cryobank sperm donors via its DNA Advantage™ Program utilizing the Sema4 Expanded Carrier Screen…”

Leadership Team